🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Next at DECISION's Networking Session at #EASL2025, Theresa Wirtz (UKA) presents scRNA-seq data showing a monocyte subset linked to ACLF risk. Fascinating translational science in action! Uniklinik RWTH AC Account not active @easlnews #scRNAseq #ACLF

Lastly at DECISION's Networking Session, Richard Moreau shares new data: high-throughput omics reveals biomarkers for infection & poor outcomes in cirrhosis. Eur. Fdn. for the Study of Chronic Liver Failure Inserm EASLnews #Metabolomics #Cytokinomics #EASL2025

Greetings from the DECISION Investigator Meeting at #EASL2025: Study updates and collaborative discussions with Paolo Caraceni & Pierre-Emmanuel Rautou EASLnews Eur. Fdn. for the Study of Chronic Liver Failure

🧊 HOPE treatment prior to organ transplant alters key immune modulators in patients receiving liver transplantation #POSTER FRI-495-YI by Maike Rebecca Pollmanns (UKA) 📅 Presented at the #EASLCongress | #EASL2025 EASLnews Uniklinik RWTH AC Account not active

🔬 #POSTER FRI-222 by Thierry Gustot (EF CLIF) proposes one-week criteria to assess the appropriateness of continuing intensive care in ACLF patients who are not candidates for liver transplantation. #EASL2025 EASLnews Eur. Fdn. for the Study of Chronic Liver Failure

DECISION consortium member Sophie Lotersztajn from the French research institute Inserm at a late-afternoon abstract session on Friday, May 9th 2025, at #EASLCongress in Amsterdam, the Netherlands, about #fibrosis, #hepatocyte and #liver #regeneration. 🩺

How do you build & lead a successful research team? The next generation of PIs learned straight from the best in today's workshop “How to Start a Research Group: From Postdoc to PI" as Rautou Pierre-Emmanuel shared practical insights on building & maintaining a high-performing team. #EASL2025

Is the etiological work-up of #PSVD a one-size-fits-all? DECISION consortium member Lucile Moga from APHP takes part in EASL/ VALDIG's session on "Do's and Don'ts in the management of Porto-Sinusoidal Vascular Disease". #EASLCongress #EASL2025 #LiverResearch EASLnews

Javier Fernandez (FCRB) is giving the hepatologist perspective on management of MDR infections in cirrhosis as part of the EASL/ESCMID Symposium: MDR infections - a challenge in decompensated cirrhosis at #EASL2025 #LiverDisease #Cirrhosis #Hepatology EASLnews

Estefania Huergo presents methylation data in AD patients, selected as best Young Investigator abstract in Basic Science at #EASL2025 - Congrats! 🎉 Navarrabiomed EASLnews #Epigenetics #LiverResearch #EASL2025

Back in the Abstract Session: Theresa Wirtz presents her scRNA-seq work on monocyte subsets and ACLF risk. Uniklinik RWTH AC Account not active EASLnews #Cirrhosis #ACLF #EASL2025

🧪 Acute kidney disease in acutely decompensated cirrhosis: impact on clinical outcomes #POSTER SAT-122-YI by Alberto Calleri (UNITO) examines how acute kidney disease affects outcomes in patients w. acutely decompensated cirrhosis. 📅 Presented at #EASLCongress | #EASL2025 EASLnews

🦠The recovery failure of fecal microbiota diversity in patients after liver transplant is associated with a complicated postoperative course #POSTER SAT-518 by Maike Rebecca Pollmanns from Uniklinik RWTH AC at #EASL2025 Account not active EASLnews

Impact of diabetes mellitus on clinical outcomes in patients with acutely decompensated cirrhosis #E_POSTER by Mimma Bonomo (UNITO) explores how coexisting diabetes mellitus affects prognosis in patients hospitalized with acute decompensation of cirrhosis #EASL2025 EASLnews

Clinical trajectories of patients with cirrhosis and ascites receiving long-term albumin #POSTER SAT-145-YI by Enrico Pompili (UNIBO) proposes a personalized management approach for patients w. cirrhosis &ascites, based on real-world data from long-term albumin therapy. #EASL2025

It’s #ClinicalTrialsDay! At DECISION, we’re proud of our COMBAT & PROSPECT trials advancing care in decompensated cirrhosis. 💡COMBAT Q&A videos in multiple languages help engage patients ➡️ youtube.com/playlist?list=… Thanks to all who make our trials possible! #LiverResearch